SLC7A11 and cancer: Certain studies posit that dysregulation of GPX4, SLC7A11, and Apoptosis-Inducing Factor Mitochondria-Associated 2 occurs in diverse cancers, suggesting their role as prognostic biomarkers for various malignancies.